News | January 21, 2008

Cardiac Pacing Exam Standardized for Japanese Clinicians

January 22, 2008 - The International Board of Heart Rhythm Examiners (IBHRE) issued the first standardized cardiac pacing exam for Japanese allied professionals, which marks the first time the IBHRE exam, designed to test professional competency in cardiac pacing, defibrillation and electrophysiology, will be tailored to the needs of a global health care system outside of the U.S.

IBHRE hopes its partnership with Japan Heart Rhythm Society (JHRS) will serve as the model for future exam tailoring and administration in countries such as China, Russia and India.
The knowledge base of the exam, which includes device functions, reportedly is for the most part a global standard. Patient management questions, however, and an understanding of the clinical culture and medicines used in Japan were considered when tailoring the exam.

“With the ICD growth rate around 50 percent and no signs of decreasing, the importance of credentialing Japanese professionals is all the more urgent,” said Charles J. Love, M.D., FACC, FAHA, FHRS, CCDS, President of the IBHRE Board of Directors. “Given the growing number of heart rhythm patients around the world and the variations of health care systems globally, the need for certification and credentialing is of utmost importance to enhance positive patient care.”

The Japanese Ministry of Health has mandated that in addition to allied professionals, sales representatives, technical advisors and anyone else having contact with patients from the medical device industry must be certified. This mandate is meant to ensure a meaningful standard of knowledge for those involved in assisting physicians and other health care workers in the implantation and management of pacemakers and ICDs.

For more information: www.HRSonline.org and www.IBHRE.org


Related Content

News | Pacemakers

March 26, 2024 — UC San Diego Health is the first health system in San Diego to successfully implant the world’s first ...

Home March 26, 2024
Home
News | Pacemakers

March 15, 2024 — Following the recent CE approval of the Solia S lead1 for LBBAP, BIOTRONIK proudly announces the world ...

Home March 15, 2024
Home
News | Pacemakers

March 15, 2024 — Following the recent CE approval of the Solia S lead1 for LBBAP, Biotronik announces the world’s first ...

Home March 15, 2024
Home
News | Pacemakers

January 5, 2024 — Medtronic, a global leader in healthcare technology, today announced it has received CE (Conformité ...

Home January 05, 2024
Home
News | Pacemakers

August 21, 2023 — The first implant in Europe of Biotronik’s latest pacemaker and CRT-P generation was conducted in ...

Home August 21, 2023
Home
News | Pacemakers

July 6, 2023 — BIOTRONIK announced U.S. Food and Drug Administration (FDA) approval of its portfolio of Amvia Edge ...

Home July 06, 2023
Home
News | Pacemakers

July 5, 2023 — Abbott announced that the U.S. Food and Drug Administration (FDA) has approved the AVEIR dual chamber (DR ...

Home July 05, 2023
Home
News | Pacemakers

June 1, 2023 — Every year more than one million people receive a pacemaker. Until now, leadless versions were only ...

Home June 01, 2023
Home
News | Pacemakers

May 25, 2023 — Abbott announced late-breaking results from the AVEIR dual-chamber (DR) i2i Investigational Device ...

Home May 25, 2023
Home
News | Pacemakers

May 12, 2023 — Biotronik, a leading global medical technology company with 60 years of experience in developing trusted ...

Home May 12, 2023
Home
Subscribe Now